Filtered By:
Therapy: Antiviral Therapy
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 2209 results found since Jan 2013.
Past, present, and future of long-term treatment for hepatitis B virus
World J Gastroenterol. 2023 Jul 7;29(25):3964-3983. doi: 10.3748/wjg.v29.i25.3964.ABSTRACTThe estimated world prevalence of hepatitis B virus (HBV) infection is 316 million. HBV infection was identified in 1963 and nowadays is a major cause of cirrhosis and hepatocellular carcinoma (HCC) despite universal vaccination programs, and effective antiviral therapy. Long-term administration of nucleos(t)ide analogues (NA) has been the treatment of choice for chronic hepatitis B during the last decades. The NA has shown a good safety profile and high efficacy in controlling viral replication, improving histology, and decreasing th...
Source: World Journal of Gastroenterology - July 21, 2023 Category: Gastroenterology Authors: Teresa Broquetas Jos é A Carrión Source Type: research
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
CONCLUSION: DAA treatment is safe and effective in HCV-infected patients with mental disorders. No specific psychiatric diagnosis lowered the chance of successful antiviral treatment.PMID:37476581 | PMC:PMC10354581 | DOI:10.3748/wjg.v29.i25.4085
Source: World Journal of Gastroenterology - July 21, 2023 Category: Gastroenterology Authors: Dorota Dybowska Dorota Zar ębska-Michaluk Piotr Rzymski Hanna Berak Beata Lorenc Marek Sitko Micha ł Dybowski W łodzimierz Mazur Magdalena Tudrujek-Zdunek Justyna Janocha-Litwin Ewa Janczewska Jakub Klapaczy ński Anna Parfieniuk-Kowerda Anna Piekarska Source Type: research
Past, present, and future of long-term treatment for hepatitis B virus
World J Gastroenterol. 2023 Jul 7;29(25):3964-3983. doi: 10.3748/wjg.v29.i25.3964.ABSTRACTThe estimated world prevalence of hepatitis B virus (HBV) infection is 316 million. HBV infection was identified in 1963 and nowadays is a major cause of cirrhosis and hepatocellular carcinoma (HCC) despite universal vaccination programs, and effective antiviral therapy. Long-term administration of nucleos(t)ide analogues (NA) has been the treatment of choice for chronic hepatitis B during the last decades. The NA has shown a good safety profile and high efficacy in controlling viral replication, improving histology, and decreasing th...
Source: World Journal of Gastroenterology - July 21, 2023 Category: Gastroenterology Authors: Teresa Broquetas Jos é A Carrión Source Type: research
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
CONCLUSION: DAA treatment is safe and effective in HCV-infected patients with mental disorders. No specific psychiatric diagnosis lowered the chance of successful antiviral treatment.PMID:37476581 | PMC:PMC10354581 | DOI:10.3748/wjg.v29.i25.4085
Source: World Journal of Gastroenterology - July 21, 2023 Category: Gastroenterology Authors: Dorota Dybowska Dorota Zar ębska-Michaluk Piotr Rzymski Hanna Berak Beata Lorenc Marek Sitko Micha ł Dybowski W łodzimierz Mazur Magdalena Tudrujek-Zdunek Justyna Janocha-Litwin Ewa Janczewska Jakub Klapaczy ński Anna Parfieniuk-Kowerda Anna Piekarska Source Type: research
Past, present, and future of long-term treatment for hepatitis B virus
World J Gastroenterol. 2023 Jul 7;29(25):3964-3983. doi: 10.3748/wjg.v29.i25.3964.ABSTRACTThe estimated world prevalence of hepatitis B virus (HBV) infection is 316 million. HBV infection was identified in 1963 and nowadays is a major cause of cirrhosis and hepatocellular carcinoma (HCC) despite universal vaccination programs, and effective antiviral therapy. Long-term administration of nucleos(t)ide analogues (NA) has been the treatment of choice for chronic hepatitis B during the last decades. The NA has shown a good safety profile and high efficacy in controlling viral replication, improving histology, and decreasing th...
Source: World Journal of Gastroenterology - July 21, 2023 Category: Gastroenterology Authors: Teresa Broquetas Jos é A Carrión Source Type: research
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
CONCLUSION: DAA treatment is safe and effective in HCV-infected patients with mental disorders. No specific psychiatric diagnosis lowered the chance of successful antiviral treatment.PMID:37476581 | PMC:PMC10354581 | DOI:10.3748/wjg.v29.i25.4085
Source: World Journal of Gastroenterology - July 21, 2023 Category: Gastroenterology Authors: Dorota Dybowska Dorota Zar ębska-Michaluk Piotr Rzymski Hanna Berak Beata Lorenc Marek Sitko Micha ł Dybowski W łodzimierz Mazur Magdalena Tudrujek-Zdunek Justyna Janocha-Litwin Ewa Janczewska Jakub Klapaczy ński Anna Parfieniuk-Kowerda Anna Piekarska Source Type: research
Past, present, and future of long-term treatment for hepatitis B virus
World J Gastroenterol. 2023 Jul 7;29(25):3964-3983. doi: 10.3748/wjg.v29.i25.3964.ABSTRACTThe estimated world prevalence of hepatitis B virus (HBV) infection is 316 million. HBV infection was identified in 1963 and nowadays is a major cause of cirrhosis and hepatocellular carcinoma (HCC) despite universal vaccination programs, and effective antiviral therapy. Long-term administration of nucleos(t)ide analogues (NA) has been the treatment of choice for chronic hepatitis B during the last decades. The NA has shown a good safety profile and high efficacy in controlling viral replication, improving histology, and decreasing th...
Source: World Journal of Gastroenterology : WJG - July 21, 2023 Category: Gastroenterology Authors: Teresa Broquetas Jos é A Carrión Source Type: research
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
CONCLUSION: DAA treatment is safe and effective in HCV-infected patients with mental disorders. No specific psychiatric diagnosis lowered the chance of successful antiviral treatment.PMID:37476581 | PMC:PMC10354581 | DOI:10.3748/wjg.v29.i25.4085
Source: World Journal of Gastroenterology : WJG - July 21, 2023 Category: Gastroenterology Authors: Dorota Dybowska Dorota Zar ębska-Michaluk Piotr Rzymski Hanna Berak Beata Lorenc Marek Sitko Micha ł Dybowski W łodzimierz Mazur Magdalena Tudrujek-Zdunek Justyna Janocha-Litwin Ewa Janczewska Jakub Klapaczy ński Anna Parfieniuk-Kowerda Anna Piekarska Source Type: research
Past, present, and future of long-term treatment for hepatitis B virus
World J Gastroenterol. 2023 Jul 7;29(25):3964-3983. doi: 10.3748/wjg.v29.i25.3964.ABSTRACTThe estimated world prevalence of hepatitis B virus (HBV) infection is 316 million. HBV infection was identified in 1963 and nowadays is a major cause of cirrhosis and hepatocellular carcinoma (HCC) despite universal vaccination programs, and effective antiviral therapy. Long-term administration of nucleos(t)ide analogues (NA) has been the treatment of choice for chronic hepatitis B during the last decades. The NA has shown a good safety profile and high efficacy in controlling viral replication, improving histology, and decreasing th...
Source: World Journal of Gastroenterology : WJG - July 21, 2023 Category: Gastroenterology Authors: Teresa Broquetas Jos é A Carrión Source Type: research
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
CONCLUSION: DAA treatment is safe and effective in HCV-infected patients with mental disorders. No specific psychiatric diagnosis lowered the chance of successful antiviral treatment.PMID:37476581 | PMC:PMC10354581 | DOI:10.3748/wjg.v29.i25.4085
Source: World Journal of Gastroenterology : WJG - July 21, 2023 Category: Gastroenterology Authors: Dorota Dybowska Dorota Zar ębska-Michaluk Piotr Rzymski Hanna Berak Beata Lorenc Marek Sitko Micha ł Dybowski W łodzimierz Mazur Magdalena Tudrujek-Zdunek Justyna Janocha-Litwin Ewa Janczewska Jakub Klapaczy ński Anna Parfieniuk-Kowerda Anna Piekarska Source Type: research
Past, present, and future of long-term treatment for hepatitis B virus
World J Gastroenterol. 2023 Jul 7;29(25):3964-3983. doi: 10.3748/wjg.v29.i25.3964.ABSTRACTThe estimated world prevalence of hepatitis B virus (HBV) infection is 316 million. HBV infection was identified in 1963 and nowadays is a major cause of cirrhosis and hepatocellular carcinoma (HCC) despite universal vaccination programs, and effective antiviral therapy. Long-term administration of nucleos(t)ide analogues (NA) has been the treatment of choice for chronic hepatitis B during the last decades. The NA has shown a good safety profile and high efficacy in controlling viral replication, improving histology, and decreasing th...
Source: World Journal of Gastroenterology : WJG - July 21, 2023 Category: Gastroenterology Authors: Teresa Broquetas Jos é A Carrión Source Type: research
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
CONCLUSION: DAA treatment is safe and effective in HCV-infected patients with mental disorders. No specific psychiatric diagnosis lowered the chance of successful antiviral treatment.PMID:37476581 | PMC:PMC10354581 | DOI:10.3748/wjg.v29.i25.4085
Source: World Journal of Gastroenterology : WJG - July 21, 2023 Category: Gastroenterology Authors: Dorota Dybowska Dorota Zar ębska-Michaluk Piotr Rzymski Hanna Berak Beata Lorenc Marek Sitko Micha ł Dybowski W łodzimierz Mazur Magdalena Tudrujek-Zdunek Justyna Janocha-Litwin Ewa Janczewska Jakub Klapaczy ński Anna Parfieniuk-Kowerda Anna Piekarska Source Type: research
Past, present, and future of long-term treatment for hepatitis B virus
World J Gastroenterol. 2023 Jul 7;29(25):3964-3983. doi: 10.3748/wjg.v29.i25.3964.ABSTRACTThe estimated world prevalence of hepatitis B virus (HBV) infection is 316 million. HBV infection was identified in 1963 and nowadays is a major cause of cirrhosis and hepatocellular carcinoma (HCC) despite universal vaccination programs, and effective antiviral therapy. Long-term administration of nucleos(t)ide analogues (NA) has been the treatment of choice for chronic hepatitis B during the last decades. The NA has shown a good safety profile and high efficacy in controlling viral replication, improving histology, and decreasing th...
Source: World Journal of Gastroenterology - July 21, 2023 Category: Gastroenterology Authors: Teresa Broquetas Jos é A Carrión Source Type: research
Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders
CONCLUSION: DAA treatment is safe and effective in HCV-infected patients with mental disorders. No specific psychiatric diagnosis lowered the chance of successful antiviral treatment.PMID:37476581 | PMC:PMC10354581 | DOI:10.3748/wjg.v29.i25.4085
Source: World Journal of Gastroenterology - July 21, 2023 Category: Gastroenterology Authors: Dorota Dybowska Dorota Zar ębska-Michaluk Piotr Rzymski Hanna Berak Beata Lorenc Marek Sitko Micha ł Dybowski W łodzimierz Mazur Magdalena Tudrujek-Zdunek Justyna Janocha-Litwin Ewa Janczewska Jakub Klapaczy ński Anna Parfieniuk-Kowerda Anna Piekarska Source Type: research
